City

Helsinki (1)

Kuopio (1)

Norfolk (1)

Oslo (1)

Oulu (1)

Tampere (1)

Turku (1)

Condition

Thrombosis, Deep Vein (4)

Pulmonary Embolism (2)

Bleeding (1)

Cerebral Stroke (1)

Embolism, Pulmonary (1)

Iliofemoral; Thrombosis (1)

Liver Cancer (1)

Surgery (1)

Overall Status

Recruiting (2)

Withdrawn (2)

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Pfizer (2)

Helsinki University Central Hospital (1)

Mercator MedSystems, Inc. (1)

Intervention

enoxaparin or tinzaparin or dalteparin (1)

no intervention (1)

perivascular dexamethasone (1)

perivascular sham (1)

Study Documents

Intervention Type

combination product (1)

drug (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

thrombosis, deep vein

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Thrombosis, Deep Vein, Iliofemoral; Thrombosis Trial in Norfolk (Perivascular dexamethasone, Perivascular sham)

Recruiting

Thrombosis, Deep Vein
Iliofemoral; Thrombosis

Perivascular dexamethasone
Perivascular sham

Norfolk, Virginia

Sentara Norfolk General Hospital

Jan 24, 2023

Liver Cancer, Surgery, Thrombosis, Deep Vein Trial in Finland, Norway (enoxaparin or tinzaparin or dalteparin, No intervention)

Recruiting

Liver Cancer
+4 more

enoxaparin or tinzaparin or dalteparin
No intervention

Helsinki, Finland
+5 more

Sep 21, 2022

Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial

Withdrawn

Cerebral Stroke
+2 more

(no location specified)

Nov 14, 2021

Adverse Events and Suspected Adverse Drug Reactions of Patients

Withdrawn

Thrombosis, Deep Vein
Pulmonary Embolism

(no location specified)

Nov 9, 2021